15,700 Shares in Myomo, Inc. (NYSEAMERICAN:MYO) Acquired by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. acquired a new stake in Myomo, Inc. (NYSEAMERICAN:MYO) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 15,700 shares of the company’s stock, valued at approximately $101,000. Jefferies Financial Group Inc. owned about 0.05% of Myomo at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Barclays PLC purchased a new stake in Myomo during the third quarter worth approximately $36,000. Calamos Advisors LLC acquired a new stake in Myomo during the fourth quarter worth approximately $189,000. Palumbo Wealth Management LLC purchased a new stake in shares of Myomo during the 4th quarter worth approximately $242,000. Thompson Davis & CO. Inc. acquired a new position in shares of Myomo in the 4th quarter valued at $181,000. Finally, Thompson Siegel & Walmsley LLC acquired a new position in shares of Myomo in the 4th quarter valued at $1,288,000. 44.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

MYO has been the topic of several research analyst reports. Ascendiant Capital Markets lifted their price target on shares of Myomo from $9.00 to $11.00 and gave the stock a “buy” rating in a research note on Monday, March 17th. Alliance Global Partners reiterated a “buy” rating on shares of Myomo in a research report on Tuesday, March 11th. HC Wainwright boosted their target price on Myomo from $7.50 to $9.50 and gave the company a “buy” rating in a report on Wednesday, March 12th. Finally, Craig Hallum dropped their price target on Myomo from $11.00 to $10.00 and set a “buy” rating on the stock in a research note on Thursday, May 8th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Myomo currently has a consensus rating of “Buy” and a consensus target price of $9.50.

Myomo Stock Up 10.5%

Shares of MYO opened at $3.57 on Monday. Myomo, Inc. has a fifty-two week low of $2.76 and a fifty-two week high of $7.17. The business’s 50-day simple moving average is $4.59. The firm has a market capitalization of $107.99 million, a P/E ratio of -15.52 and a beta of 1.68.

Insider Buying and Selling at Myomo

In other Myomo news, CEO Paul R. Gudonis bought 30,000 shares of the business’s stock in a transaction dated Thursday, May 15th. The stock was acquired at an average cost of $3.22 per share, with a total value of $96,600.00. Following the purchase, the chief executive officer now owns 1,051,671 shares in the company, valued at approximately $3,386,380.62. This represents a 2.94% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Thomas F. Kirk purchased 50,000 shares of the firm’s stock in a transaction that occurred on Monday, May 12th. The stock was acquired at an average price of $3.35 per share, for a total transaction of $167,500.00. Following the completion of the purchase, the director now owns 305,933 shares of the company’s stock, valued at approximately $1,024,875.55. This represents a 19.54% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 126,167 shares of company stock valued at $427,093 in the last ninety days. Insiders own 4.54% of the company’s stock.

About Myomo

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.